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Aim To describe characteristics and outcome of mechani-
cally ventilated patients admitted to three newly estab-
lished intensive care units (ICU) in Bosnia-Herzegovina and 
Serbia for 2009 H1N1 influenza infection.
Methods The retrospective observational study included 
all mechanically ventilated adult patients of three univer-
sity-affiliated hospitals between November 1, 2009 and 
March 1 2010 who had 2009 H1N1 influenza infection 
confirmed by real-time reverse transcriptase-polymerase-
chain-reaction (RT-PCR) from nasopharyngeal swab speci-
mens and respiratory secretions.
Results The study included 50 patients, 31 male (62%), 
aged 43 ± 13 years. Median time from hospital to ICU ad-
mission was 1 day (range 1-2). Sixteen patients (30%) 
presented with one or more chronic medical condition: 
8 (16%) with chronic lung disease, 5 (10%) with chronic 
heart failure, and 3 (6%) with diabetes mellitus. Thirty-two 
(64%) were obese. Forty-eight patients (96%) experienced 
acute respiratory distress syndrome (ARDS), 28 (56%) sep-
tic shock, and 27 (54%) multiorgan failure. Forty-five pa-
tients (90%) were intubated and mechanically ventilated, 
5 received non-invasive mechanical ventilation, 7 (14%) 
high-frequency oscillatory ventilation, and 7 (14%) renal 
replacement therapy. The median duration of mechanical 
ventilation was 7 (4-14) days. Hospital mortality was 52%.
Conclusion Influenza 2009 H1N1 infection in three south-
east European ICUs affected predominantly healthy young 
patients and was associated with rapid deterioration after 
hospital admission and severe respiratory and multiorgan 
failure. These emerging ICUs provided contemporary ICU 
services, resulting in case-fatality rate comparable to re-
ports from well-established ICU settings.
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After the first cases of human influenza A H1N1 infection 
were observed in Mexico in April 2009 (1), the infection 
quickly spread to Europe, Asia, and both Americas, which 
is why the World Health Organization (WHO) declared level 
6 pandemic alert on June 11, 2009 (2). Up to February 2010, 
influenza A H1N1 virus was confirmed in more than 212 
countries and caused more than 15 000 deaths (3).
Compared with seasonal influenza, pandemic 2009 H1N1 
influenza A has affected a great number of young, previ-
ously healthy patients and caused significant health and 
economic burden even in developed countries. So far, sev-
eral studies have reported their experience with critically 
ill patients with 2009 H1N1 influenza in North America, 
South America, Asia, Australia, and Europe (1,4-12). A few 
studies have so far reported on H1N1 patients’ characteris-
tics and outcome in low-income and developing countries 
with limited ICU resources (1,8-12), and none on that in the 
west Balkans. The ICUs in these countries are mainly run by 
physicians who lack formal ICU training. Furthermore, until 
only recently non-surgical critically ill patients in these ICUs 
had limited access to mechanical ventilation and other life 
support interventions. However, over the past five years, 
three university hospitals in Bosnia and Herzegovina and 
Serbia have established multidisciplinary medical ICUs and 
most of critically ill patients with H1N1 influenza A infec-
tion in the region were admitted to these units.
The aim of this study was to describe characteristics and 
outcomes of mechanically ventilated adult patients with 
2009 H1N1 influenza A infection treated in these ICUs.
MATeriAlS ANd MeThodS
A retrospective observational study was conducted in the 
ICUs of three university-affiliated hospitals: Clinical Center 
of University in Sarajevo (5 beds, medical ICU), University 
Hospital of Banja Luka, Banja Luka (6 beds, medical ICU) 
(Bosnia and Herzegovina), and the Institute for Pulmonary 
Diseases of Vojvodina, Sremska Kamenica (5 beds, medi-
cal ICU) (Serbia) between November 1, 2009 and March 1, 
2010. All three ICUs have been established in the last five 
years (Sarajevo in 2009, Banja Luka in 2008, and Sremska 
Kamenica in 2003) with support of critical care specialists 
trained in the United States and Europe, members of the 
European Society of Intensive Care Medicine, and the Soci-
ety of Critical Care Medicine (13).
The study included all mechanically ventilated patients 
with 2009 influenza A(H1N1) virus infections. Patients had 
novel Influenza A (H1N1) infection confirmed by real-time 
reverse transcriptase polymerase chain reaction (RTC-
PCR) from nasopharyngeal swab specimens and respi-
ratory secretions at the time of hospital admission. Data 
were extracted from pre-existing hospital charts including 
demographic data, vital signs, laboratory parameters, ra-
diological data, mechanical ventilation details, and chronic 
medical conditions: chronic obstructive pulmonary dis-
ease, asthma, congestive heart failure, neoplasm, chronic 
liver or renal diseases, diabetes mellitus, and the use of 
immunosuppressant medications. Severity of illness was 
assessed according to the Acute Physiology and Chronic 
Health Evaluation (APACHE) II score (14). Standardized defi-
nitions were used to determine the presence or absence 
of ICU complications including acute respiratory distress 
syndrome (ARDS) (15) and shock (16). The study protocol 
was approved by the Institutional Review Boards, which 
waived the need for additional informed consent due to 
an observational study design.
Statistical analyses
Data are expressed as the mean and standard deviation for 
normally distributed or as median and interquartile range 
for not normally distributed continuous variables, and 
counts with percentages for categorical variables. Com-
parison of measures for continuous variables was done us-
ing Wilcoxon rank sum test. Comparison of proportion was 
done using χ2 square test and Fisher exact test as appropri-
ate. Statistical analyses were performed using JMP statisti-
TABle 1. Characteristics of mechanically ventilated patients 
with 2009 influenza A(h1N1) confirmed infection*
Characteristic
Age, median (range), y 43 (35-54)
Male sex, n (%) 31 (62)
APACHE II (mean ± standard deviation) 19 ± 11
SOFA on day 1 (mean ± standard deviation)  8 ± 4
Chronic medical conditions, n (%)† 16 (32)
Obesity (BMI>30), n (%) 32 (64)
Ever smoker, n (%) 14 (28)
Chronic respiratory disease, n (%)  8 (16)
Congestive heart failure, n (%)  5 (10)
Diabetes, n (%)  3 (6)
Immunosuppression, n (%)  3 (6)
Pregnancy, n (%)  4 (8)
*Abbreviations: APAChe – Acute Physiology and Chronic health 
evaluation; SoFA – Sequential organ Failure Assessment; BMi – body 
mass index.
†indicates presence of chronic respiratory diseases, congestive heart 
failure, diabetes, immunosupresion, malignancy, chronic renal or liver 
disease.
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cal software (JMP 7, SAS institute, Cary, NC, USA). P-values 
<0.05 were considered statistically significant.
reSUlTS
Clinical characteristics
A total of 50 patients, 31 men (62%), mean age 43 ± 13 
years, were admitted to medical ICUs of three tertiary care 
hospitals (Table 1). Mean Apache II score was 19 ± 11. The 
most frequent comorbidities were obesity, smoking, and 
chronic respiratory disease (Table 1). Two thirds of patients 
did not have any chronic medical condition. The median 
time from hospital admission to ICU admission was 1 day 
(1-2 days). Antiviral treatment was initiated on average six 
days after symptom onset.
respiratory failure
Forty-seven patients (94%) presented with bilateral infil-
trates on chest radiographs at the ICU admission and 48 
patients (96%) developed ARDS. The median P/F ratio (ar-
terial oxygen concentration to the fraction of inspired oxy-
gen) on day 1 was 75 mm Hg (interquartile range, 57-129). 
The proportion of patients with bilateral infiltrate was simi-
lar among survivors and non survivors. However the P/F 
ratio was significantly lower among non survivors (121 vs 
59, P < 0.001) (Table 2). Forty-five patients (90%) were in-
tubated and mechanically ventilated and 8 received tra-
cheostomy. Five patients were treated with non-invasive 
mechanical ventilation only, and all of them survived. High 
frequency oscillation was used in 7, and renal replacement 
therapy in 7 patients.
TABle 2. Characteristics of survivors and non survivors on intensive care unit (iCU) admission
Survivors (N = 24) Non-survivors (N = 26) P
Baseline characteristics
Age (median, IQR), y  42 (32-53)  43 (35-55) 0.816†
Male sex, n (%)  16 (52)  15 (48) 0.514‡
Ever smoker, n (%)   7 (29)   7 (27) 0.860‡
BMI (median, IQR)  30 (27-32)  30 (26-34) 0.881†
Any comorbidities, n (%)   7 (29)   9 (35) 0.680‡
Chronic pulmonary disease   4 (17)   4 (15) 1.000§
CHF   2 (8)   3 (12) 1.000§
Diabetes mellitus   2 (9)   1(4) 0.602§
Immunosupression   0 (0)   3 (12) 0.236§
Pregnancy, n (%)   1 (4)   3 (12) 0.610§
iCU admission characteristics
Apache IIa (median, IQR)  13 (5-18)  24 (15 -31) <0.001†
SOFA day 1a (median, IQR)   5 (3-8)   8 (7-13) <0.001†
GCSa (median, IQR)  15 (15-15)  10 (8-15) 0.001†
Temperature (°C)b (median, IQR)  38 (37-39)  39 (37-39) 0.741†
Heart ratea (median, IQR) 108 (100-130) 129 (113-141) 0.011†
Systolic blood pressure (mmHg) (median, IQR) 110 (98-130)  90 (82-116) 0.018†
Respiratory rate (per min) (median, IQR)  26 (20-38)  36 (30-45) 0.008†
Pao2/FiO2 d 1
b, (median, IQR) 121(76-199)  59 (50-80) <0.001†
WBC countb 109/L, (median, IQR)   6 (5-7)   4 (2-8) 0.077†
Hctb, (median, IQR)  35 (32-47)  34 (28-32) 0.594†
Platelet countb 103/μL, (median, IQR) 185 (133-224) 127 (89-168) 0.077†
Ureab mmol/L, (median, IQR)   5 (3-7)   8 (5-13) 0.016†
Creatininb mg/dL, (median, IQR)  78 (69-99) 106 (84-181) 0.002†
Bilirubinb μmol/L, (median, IQR)   9 (7-15)  14 (7-19) 0.376†
Bilateral infiltrates, n (%)  21 (87)  26 (100) 0.103§
*Abbreviations: BMi – body mass index; ChF – congestive heart failure; APAChe – Acute Physiology and Chronic health evaluation; SoFA- Sequential 
organ Failure Assessment; GCS-Glasgow Coma Scale; iQr – interquartile range;a at the time of iCU admission, b worst value on day 1.
†Wilcoxon rank sum test.
‡χ2 test.
§Fisher exact test.
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Non pulmonary organ failure
Fourteen (28%) patients required vasoactive medications on 
day 1, but 28 (56%) eventually developed septic shock and 
27 (54%) multiorgan failure. Six (12%) patients required he-
modialysis. Hemodynamic, neurological, and renal impair-
ment were more frequent among non-survivors (Table 2).
outcomes
The median duration of mechanical ventilation was 7 days 
(4-14 days) and median ICU length of stay was 10 days 
(5-22 days). Overall hospital mortality was 52% (n = 26). 
The mortality rates were higher in pregnant (75%, 3/4) and 
obese patients (53%, 17/32). The time from the symptom 
onset to administration of oseltamivir was longer in non-
survivors than survivors, although the difference was not 
significant. Higher severity of illness scores and hypoxemia 
on admission were strongly associated with increased 
mortality (Table 2, Table 3).
diSCUSSioN
We report on the first series of critically ill patients from 
southeastern Europe admitted to 3 newly established ICUs 
for confirmed influenza A (H1N1) infection requiring me-
chanical ventilation. Patients were mostly young and most 
of them did not have any chronic medical condition. Obe-
sity was the most frequently associated comorbidity. All 
patients presented with severe hypoxemic respiratory fail-
ure and most of them with hemodynamic failure. In terms 
of patients’ characteristics, our results are consistent with 
previously published data (1,4-12).
In the west Balkans, the outbreak of the novel influenza virus 
began in the late fall of 2009, and its impact was assessed 
during the winter flu season. Similar to previous studies, we 
observed a higher percentage of critically ill among young, 
previously healthy patients than was the case with season-
al influenza (1,4-12,17). The most common chronic medical 
conditions were chronic lung diseases and 30% of patients 
had a history of smoking. Although obesity was common, 
there was no difference in body mass index between sur-
vivors and non-survivors. Patients experienced rapid de-
terioration following hospitalization and presented with 
ARDS, often combined with septic shock and multiorgan 
failure, with a great need for rescue therapies such as renal 
replacement therapy of high-frequency oscillatory ventila-
tion. There was a high occurrence of complications such 
as prolonged mechanical ventilation and ventilator-asso-
ciated pneumonia. Inhaled nitric oxide and extracorporeal 
membrane oxygenation were not available. The number of 
days on mechanical ventilation and average length of stay 
were similar to other studies (4,7).
Previous studies reported on young patients with very se-
vere critical illness (Table 4). Obesity was the most com-
mon comorbidity, ranging from 21% to 64% in all patients. 
Although there were some discrepancies between the 
studies, the number of patients with no comorbidities was 
substantial, ranging from 15% to 64%, except in one study 
(4), in which it was only 1.7%. The pattern of the respira-
tory failure was similar across the studies as most patients 
developed a severe form of ARDS. The level of hypoxemia 
was high in all studies. Hemodynamic failure was also fre-
quently present, which is consistent with previously pub-
lished data (1,6,9,10,12). In our study, the majority of pa-
tients were treated with invasive mechanical ventilation. In 
other studies, this proportion ranged from 1% (1) to 19% 
(9). Mortality rates found in our study were similar to those 
from other studies, ranging between 40% and 50% in the 
majority of the studies. Only a Canadian study (4) report-
ed a 21% mortality rate, whereas a South African study 
reported a 68% mortality rate (10). The mortality rate 
in our study was comparable to those in other tran-





(N = 26) P
interventions and complications
Time to oseltamivir, days 
(median, IQR)
 5 (4-8)  6 (5-7)  0.234†
ARDS, n (%) 22 (92) 26 (100)  0.225‡
Septic shock, n (%)  5 (21) 23 (88) <0.001§
MODS, n (%)  9 (43) 18 (95) <0.001§
Dialysis, n (%)  1 (4)  6 (23)  0.100‡
Neuromuscular blockers, n (%)  7 (30) 14 (54)  0.077§
High frequency oscillatory 
ventilation, n (%)
 0 (0)  7 (27)  0.010‡
Tracheostomy, n (%)  5 (21)  3 (11)  0.456‡
Ventilator associated 
pneumonia, n (%)
 8 (33) 12 (46)  0.355§
outcomes
Mechanical ventilation, days 
(median, IQR)
 7 (4-10) 10 (4-18)  0.572†
ICU length of stay, days 
(median, IQR)
10 (7-33) 10 (4-18)  0.158†
*Abbreviations: ArdS – acute respiratory distress syndrome; ModS – 
multiple organ dysfunction syndrome; iCU – intensive care unit; iQr 
– interquartile range.
†Wilcoxon rank sum test.
‡χ2 test.
§Fisher exact test.
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TABle 4. Comparison of studies reporting characteristics and outcome of patients with influenze A(h1N1) virus infection requiring mechanical 
ventilation
Canada (4) Mexico (1) Argentina (9) Uruguay (8) South Africa (10) india (12) Spain (6)
Southeastern 
europe (our data)
Patients, N  16 58 337  96  19 31 32  50
Ventilated patients, n (%) 136 (81) 54 (93) 337 (100)  96 (100)  19 (100) 22 (71) 24 (75)  50 (100)
epidemiology and risk factors:
H1N1 confirmed, n (%) 162 (94) 29 (50) 132 (39)  77 (80)  NA 31 (100) 32 (100)  50 (100)
age, y (mean±SD or median 
and range)
 32 ± 21 44 (10-83)  47 ± 17  45 ± 14  39.5 ± 14.8 35 (28-43) 36 (31-52)  43 (35-54)
female/male (ratio)  67/33 53/37  44/56  44/56  79/21 42/58 27/73  38/62
APACHE II, mean ± SD  19.7 ± 8.7 20.1 ± 11.9  18 ± 7  18 ± 8  18 ± 5 13.9 ± 6.9 13.8 ± 6.4  18.7 ± 10.6
SOFA, mean ± SD   6.8 ± 3.6  9 ± 4.3  NA   5.8 ± 2.2  NA  NA  7.1 ± 3.3   7.7 ± 3.7
no comorbidity, n (%)   3 (1.7)  9/58 (15) 121 (36)  27 (24)   3 (16) 20 (35) 15 (47)  34 (68)
diabetes, n (%)  35 (21) 10 (17)  41 (12)  14 (15)   6 (32)  3 (9.7)  1 (3)   3 (6)
immunosuppression, n (%)  33 (20)  2 (3.4)  50 (15)   8 (8)   6 (32)  1 (3.2)  NA   3 (6)
COPD, n (%)  16 (9.5)  2 (3.4)  61 (18)  17 (17)   1 (5)  1 (3.2)  4 (12.5)   6 (12)
obesity, n (%)  56 (33.3) 21 (36)  80 (24)  37 (39)   4 (21)  9 (29) 10 (31)  32 (64)
pregnancy, n (%)  13 (7.7)  1 (1.7)  22 (7)   6 (6)   6 (32)  3 (9.7)  2 (6)   3 (6)
Time periods:
time from onset to hospital-
ization, days (median and IQR)
  4 (2-7)  6 (4-8)   6 (3-8)   4 (2-7)  NA  NA  NA  NA
time from hospitalization to 
ICU, days (median and IQR)
  1 (0-2)  1 (0-3)   0 (0-2)   0 [0-2]  NA  NA  NA   1 (1-2)
time from symptoms onset to 
ICU, days (median and IQR)
 NA  NA  NA  NA  NA  6(5-7)  3 (2-6)  NA
Ventilation parameters:
Pao2/FiO2 on admission 
(mmHg, mean±SD or median 
and range)
147 ± 128 83 (59-145) 107 (75-150) 116 (73-220) 171 ± 74  NA  NA 103 ± 63
Pao2/FiO2 < 100  NA  NA 151 (45)  NA   3 (16) 12 (38.7)  NA  NA
NIV only   8 (5)  6 (1)  64 (19)  10 (10.4)   2 (10)  4 (12.9)  2 (6)   5 (10)
prone   5 (3)  NA  43 (13)  25 (26)  NA  9 (40.9)  8 (25)   2 (4)
ECMO   7 (4.2)  0   0   7   0  0  0   0
other organ failures and treatment:
shock (or vasopressors) on 
admission, n (%)
 55 (33) 34 (58.6)  NA  NA  NA  NA  NA  14 (28)
shock (or vasopressors) 
during the ICU stay, n (%)
 NA  NA 242 (72)  NA   8 (42) 18 (58.1) 30 (62)  28 (56)
corticosteroids, n (%)  85 (50.1) 40 (69)  NA  53 (55)   2 (10)  NA  NA  NA
renal replacement therapy, 
n (%)
 NA  NA  55 (17)  NA   3 (16)  4 (12.9)  7 (22)   7 (14)
outcome:
duration of mechanical 
ventilation (median, IQR)
 12 (6-20) 15 (8-26) S
 3 (3-13) nonS
 10 (5-16)   9 (2-14) S
  9 (4-16) nonS
 NA 10 (4-22) 10 (1-21) S   7 (4-14)
length of stay in the ICU 
(median, IQR)
 12 (5-20) 13.5 (6-24) S
 7 (2-13) Non S
 12 (6-20)  10 (4-19) S
 10 (4-16) Non S 
 15 ± 11 10 (5-17)  NA  10 (5-22)
overall mortality, n (%)  29 (17.3) 24(41.4) 156 (46)  48 (50)  13 (68)  6 (19.4)  8/32 (25†)  26 (52)
mortality in mechanically 
ventilated patients, n (%)
 29 (21) 24(44.4) 156 (46)  48 (50)  13 (68)  NA  8/24 (33†)  26 (52)
*Abbreviation: S – survivors; non S – non-survivors; Sd – standard deviation; APAChe – Acute Physiology and Chronic health evaluation; SoFA – Sequential organ 
Failure Assessment; CoPd – chronic obstructive pulmonary disease; iCU – intensive care unit; NiV – noninvasive mechanical ventilation; eCMo – extracorporeal 
membrane oxygenation; iQr – interquartile range.
†28-d mortality. 2 more deaths at day 31 and 65, + at day of submission, 5/28 patients were still ventilated.
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TABle 4. Comparison of studies reporting characteristics and outcome of patients with influenze A(h1N1) virus infection requiring mechanical 
ventilation
Canada (4) Mexico (1) Argentina (9) Uruguay (8) South Africa (10) india (12) Spain (6)
Southeastern 
europe (our data)
Patients, N  16 58 337  96  19 31 32  50
Ventilated patients, n (%) 136 (81) 54 (93) 337 (100)  96 (100)  19 (100) 22 (71) 24 (75)  50 (100)
epidemiology and risk factors:
H1N1 confirmed, n (%) 162 (94) 29 (50) 132 (39)  77 (80)  NA 31 (100) 32 (100)  50 (100)
age, y (mean±SD or median 
and range)
 32 ± 21 44 (10-83)  47 ± 17  45 ± 14  39.5 ± 14.8 35 (28-43) 36 (31-52)  43 (35-54)
female/male (ratio)  67/33 53/37  44/56  44/56  79/21 42/58 27/73  38/62
APACHE II, mean ± SD  19.7 ± 8.7 20.1 ± 11.9  18 ± 7  18 ± 8  18 ± 5 13.9 ± 6.9 13.8 ± 6.4  18.7 ± 10.6
SOFA, mean ± SD   6.8 ± 3.6  9 ± 4.3  NA   5.8 ± 2.2  NA  NA  7.1 ± 3.3   7.7 ± 3.7
no comorbidity, n (%)   3 (1.7)  9/58 (15) 121 (36)  27 (24)   3 (16) 20 (35) 15 (47)  34 (68)
diabetes, n (%)  35 (21) 10 (17)  41 (12)  14 (15)   6 (32)  3 (9.7)  1 (3)   3 (6)
immunosuppression, n (%)  33 (20)  2 (3.4)  50 (15)   8 (8)   6 (32)  1 (3.2)  NA   3 (6)
COPD, n (%)  16 (9.5)  2 (3.4)  61 (18)  17 (17)   1 (5)  1 (3.2)  4 (12.5)   6 (12)
obesity, n (%)  56 (33.3) 21 (36)  80 (24)  37 (39)   4 (21)  9 (29) 10 (31)  32 (64)
pregnancy, n (%)  13 (7.7)  1 (1.7)  22 (7)   6 (6)   6 (32)  3 (9.7)  2 (6)   3 (6)
Time periods:
time from onset to hospital-
ization, days (median and IQR)
  4 (2-7)  6 (4-8)   6 (3-8)   4 (2-7)  NA  NA  NA  NA
time from hospitalization to 
ICU, days (median and IQR)
  1 (0-2)  1 (0-3)   0 (0-2)   0 [0-2]  NA  NA  NA   1 (1-2)
time from symptoms onset to 
ICU, days (median and IQR)
 NA  NA  NA  NA  NA  6(5-7)  3 (2-6)  NA
Ventilation parameters:
Pao2/FiO2 on admission 
(mmHg, mean±SD or median 
and range)
147 ± 128 83 (59-145) 107 (75-150) 116 (73-220) 171 ± 74  NA  NA 103 ± 63
Pao2/FiO2 < 100  NA  NA 151 (45)  NA   3 (16) 12 (38.7)  NA  NA
NIV only   8 (5)  6 (1)  64 (19)  10 (10.4)   2 (10)  4 (12.9)  2 (6)   5 (10)
prone   5 (3)  NA  43 (13)  25 (26)  NA  9 (40.9)  8 (25)   2 (4)
ECMO   7 (4.2)  0   0   7   0  0  0   0
other organ failures and treatment:
shock (or vasopressors) on 
admission, n (%)
 55 (33) 34 (58.6)  NA  NA  NA  NA  NA  14 (28)
shock (or vasopressors) 
during the ICU stay, n (%)
 NA  NA 242 (72)  NA   8 (42) 18 (58.1) 30 (62)  28 (56)
corticosteroids, n (%)  85 (50.1) 40 (69)  NA  53 (55)   2 (10)  NA  NA  NA
renal replacement therapy, 
n (%)
 NA  NA  55 (17)  NA   3 (16)  4 (12.9)  7 (22)   7 (14)
outcome:
duration of mechanical 
ventilation (median, IQR)
 12 (6-20) 15 (8-26) S
 3 (3-13) nonS
 10 (5-16)   9 (2-14) S
  9 (4-16) nonS
 NA 10 (4-22) 10 (1-21) S   7 (4-14)
length of stay in the ICU 
(median, IQR)
 12 (5-20) 13.5 (6-24) S
 7 (2-13) Non S
 12 (6-20)  10 (4-19) S
 10 (4-16) Non S 
 15 ± 11 10 (5-17)  NA  10 (5-22)
overall mortality, n (%)  29 (17.3) 24(41.4) 156 (46)  48 (50)  13 (68)  6 (19.4)  8/32 (25†)  26 (52)
mortality in mechanically 
ventilated patients, n (%)
 29 (21) 24(44.4) 156 (46)  48 (50)  13 (68)  NA  8/24 (33†)  26 (52)
*Abbreviation: S – survivors; non S – non-survivors; Sd – standard deviation; APAChe – Acute Physiology and Chronic health evaluation; SoFA – Sequential organ 
Failure Assessment; CoPd – chronic obstructive pulmonary disease; iCU – intensive care unit; NiV – noninvasive mechanical ventilation; eCMo – extracorporeal 
membrane oxygenation; iQr – interquartile range.
†28-d mortality. 2 more deaths at day 31 and 65, + at day of submission, 5/28 patients were still ventilated.
sitional countries (1,8,9), but higher than in some reports 
from Western countries, with longer tradition of intensive 
care medicine (4,6,7,18). The high morbidity and mortality 
rate in patients with confirmed 2009 H1N1 influenza im-
posed significant burden even on well developed coun-
tries and advanced ICU settings. Many previous reports 
(19-21) emphasized the potential problem of ICU’s unpre-
paredness for the upcoming pandemic. Physicians in Bos-
nia and Herzegovina and Serbia, as well as in the majority 
of countries in Eastern Europe, lack official ICU training (13) 
and use annual meetings and conferences as sources of 
information. This all affects the quality and availability of 
the ICU resources, especially in cases when there is a need 
for advanced rescue therapies. The contemporary ICUs are 
available in a small number of centers throughout the re-
gion, with restricted number of beds, and when faced with 
increased demands, the consequences can be devastat-
ing. In Bosnia and Herzegovina and Serbia, the 2009 win-
ter outbreak had occurred before massive vaccination was 
introduced and appropriate antiviral therapy in severely ill 
patients during the epidemic was generally delayed.
It is noteworthy that all 3 ICUs have been set up recently, 
one of them had opened 3 months before the breakout 
of the pandemic, with poorly trained staff and inappropri-
ate equipment (infusion pumps were not available in one 
ICU during the whole study period and renal replacement 
therapy was inconstantly possible to perform). In spite of 
all this, half of the patients survived.
Intensive care medicine is frequently considered to have 
lower priority in low and middle income countries (22-
24). Although costs of intensive care are high, population 
based studies have proven it “very cost effective” according 
to WHO definition (25-27).
The limitations of our study are related to a relatively small 
number of patients. The study included patients from 
three tertiary care centers who required mechanical ven-
tilation and ICU admission and underwent routine testing 
for H1N1 infection the flu season. This may not necessarily 
be representative of all regional centers, and the total bur-
den of pandemic in the region is likely to be higher. The 
study was performed on the patients with the most severe 
form of disease, requiring intensive care and is not repre-
sentative of less severe cases who did not require admis-
sion to the ICU. Finally, high frequency oscillation was avail-
able only in one center and some rescue therapies such as 
extracorporeal membrane oxygenation and inhaled nitric 
oxide were not accessible at all.
The novel 2009 H1N1 influenza in Bosnia and Herzegovina 
and Serbia showed similar characteristics to those report-
ed in other studies from around the world, affecting pre-
dominantly young healthy individuals and those with no 
comorbidities. Patients presented with severe ARDS, had a 
great need for rescue therapies, and a high mortality. In an 
area with low access to intensive care and physicians’ lack 
of training in intensive care medicine, these three newly 
established ICUs achieved a survival rate similar to that in 
other transitional countries, and slightly lower than in de-
veloped countries.
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